- Home
- Publications
- Publication Search
- Publication Details
Title
Integrating biomarkers in clinical trials
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 11, Issue 2, Pages 171-182
Publisher
Informa UK Limited
Online
2011-03-15
DOI
10.1586/erm.10.120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
- (2010) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations
- (2010) Aiyi Liu et al. Clinical Trials
- A Bayesian adaptive design with biomarkers for targeted therapies
- (2010) Jens C Eickhoff et al. Clinical Trials
- Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials
- (2010) Sue-Jane Wang et al. Clinical Trials
- Clinical trials for predictive medicine: new challenges and paradigms
- (2010) Richard Simon Clinical Trials
- The efficiency of clinical trial designs for predictive biomarker validation
- (2010) KY Young et al. Clinical Trials
- Bayesian adaptive randomization designs for targeted agent development
- (2010) J. Jack Lee et al. Clinical Trials
- Adjusted significance levels for subgroup analyses in clinical trials
- (2010) Bart Spiessens et al. Contemporary Clinical Trials
- Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab
- (2010) Fabrice Andre et al. JOURNAL OF CLINICAL ONCOLOGY
- Selecting Systemic Cancer Therapy One Patient at a Time: Is There a Role for Molecular Profiling of Individual Patients With Advanced Solid Tumors?
- (2010) James H. Doroshow JOURNAL OF CLINICAL ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
- (2010) Bryan T.J. Hennessy et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
- (2010) Federico Cappuzzo et al. LANCET ONCOLOGY
- Gene-expression-based prognostic assays for breast cancer
- (2010) Chungyeul Kim et al. Nature Reviews Clinical Oncology
- Molecular markers to individualize adjuvant therapy for colon cancer
- (2010) Tara Gangadhar et al. Nature Reviews Clinical Oncology
- What should physicians look for in evaluating prognostic gene-expression signatures?
- (2010) Jyothi Subramanian et al. Nature Reviews Clinical Oncology
- Biomarkers and surrogate end points—the challenge of statistical validation
- (2010) Marc Buyse et al. Nature Reviews Clinical Oncology
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing Trial Design
- (2009) Cyrus Mehta et al. CIRCULATION
- Effective Incorporation of Biomarkers into Phase II Trials
- (2009) L. M. McShane et al. CLINICAL CANCER RESEARCH
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All
- (2009) Sumithra J. Mandrekar et al. Journal of Biopharmaceutical Statistics
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- INTERESTing Biomarker to Select IDEAL Patients for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Yes, forEGFRMutation Analysis, Others, I PASS
- (2009) Ramaswamy Govindan JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
- (2009) S. E. Taube et al. JNCI-Journal of the National Cancer Institute
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
- (2009) Richard Simon Personalized Medicine
- Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
- (2009) Werner Brannath et al. STATISTICS IN MEDICINE
- Genomic advances and their impact on clinical trial design
- (2009) Sumithra J Mandrekar et al. Genome Medicine
- Statistical Issues in Translational Cancer Research
- (2008) S. L. George CLINICAL CANCER RESEARCH
- The Use of Genomics in Clinical Trial Design
- (2008) R. Simon CLINICAL CANCER RESEARCH
- Randomized Phase III Clinical Trial Designs for Targeted Agents
- (2008) A. Hoering et al. CLINICAL CANCER RESEARCH
- A predictive probability design for phase II cancer clinical trials
- (2008) J Jack Lee et al. Clinical Trials
- Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine
- (2008) Xian Zhou et al. Clinical Trials
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- A flexible strategy for testing subgroups and overall population
- (2008) Mohamed Alosh et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now